MAP2K1 and cardiac hypertrophy: The results demonstrated that galangin significantly ameliorated cardiac function and inhibited cardiac hypertrophy and fibrosis by disruption of PI3K–Akt–GSK3β and MEK1/2–ERK1/2–GATA4 signaling after pressure overload in vivo and Ang II‐stimulation in vitro.